Cargando…

Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity

BACKGROUND: Mutations in the GBA gene, which encodes the lysosomal enzyme glucocerebrosidase (GCase), are risk factors for Parkinson's disease (PD). OBJECTIVE: To explore the association between GCase activity, PD phenotype, and probability for prodromal PD among carriers of mutations in the GB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omer, Nurit, Giladi, Nir, Gurevich, Tanya, Bar‐Shira, Anat, Gana‐Weisz, Mali, Glinka, Tal, Goldstein, Orly, Kestenbaum, Meir, Cedarbaum, Jesse M., Mabrouk, Omar S., Fraser, Kyle B., Shirvan, Julia C., Orr‐Urtreger, Avi, Mirelman, Anat, Thaler, Avner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292990/ https://www.ncbi.nlm.nih.gov/pubmed/34550621 http://dx.doi.org/10.1002/mds.28792

Ejemplares similares

Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers
por: Thaler, Avner, et al.
Publicado: (2021)

Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease
por: Thaler, Avner, et al.
Publicado: (2020)

C9orf72-G(4)C(2) Intermediate Repeats and Parkinson’s Disease; A Data-Driven Hypothesis
por: Kobo, Hila, et al.
Publicado: (2021)

The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews
por: Shiner, Tamara, et al.
Publicado: (2021)

R869C mutation in molecular motor KIF17 gene is involved in dementia with Lewy bodies
por: Goldstein, Orly, et al.
Publicado: (2021)

A Personalized Approach to Parkinson’s Disease Patients Based on Founder Mutation Analysis
por: Giladi, Nir, et al.
Publicado: (2016)

Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease
por: Kozlovski, Tal, et al.
Publicado: (2019)

The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol
por: Bregman, Noa, et al.
Publicado: (2023)

Correction: The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol
por: Bregman, Noa, et al.
Publicado: (2023)

Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease
por: Kedmi, Merav, et al.
Publicado: (2011)

Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
por: Droby, Amgad, et al.
Publicado: (2022)

Effects of Aging on Arm Swing during Gait: The Role of Gait Speed and Dual Tasking
por: Mirelman, Anat, et al.
Publicado: (2015)

Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
por: Ben Bashat, Dafna, et al.
Publicado: (2022)

Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequences
por: Droby, Amgad, et al.
Publicado: (2021)

Overnight Distribution of REM Sleep Features in People with Parkinson’s Disease (PD) and Non-PD Controls
por: Dagay, Andrew, et al.
Publicado: (2023)

Imaging Markers in Genetic Forms of Parkinson’s Disease
por: Droby, Amgad, et al.
Publicado: (2023)

FUS-P525L Juvenile Amyotrophic Lateral Sclerosis and Intellectual Disability: Evidence for Association and Oligogenic Inheritance
por: Goldstein, Orly, et al.
Publicado: (2022)

Subthalamic Neurons Encode Both Single- and Multi-Limb Movements in Parkinson’s Disease Patients
por: Tankus, Ariel, et al.
Publicado: (2017)

A novel performance scoring quantification framework for stress test set-ups
por: Kozlovski, Tal, et al.
Publicado: (2023)

Automated detection of missteps during community ambulation in patients with Parkinson’s disease: a new approach for quantifying fall risk in the community setting
por: Iluz, Tal, et al.
Publicado: (2014)

SPARC: a new approach to quantifying gait smoothness in patients with Parkinson’s disease
por: Beck, Yoav, et al.
Publicado: (2018)

GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder
por: Gan-Or, Ziv, et al.
Publicado: (2015)

FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease
por: Matthews, Dawn C., et al.
Publicado: (2018)

Sensor-Based and Patient-Based Assessment of Daily-Living Physical Activity in People with Parkinson’s Disease: Do Motor Subtypes Play a Role?
por: Galperin, Irina, et al.
Publicado: (2020)

Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
por: Shkury, Eden, et al.
Publicado: (2023)

Paroxysmal Slow-Wave Events Are Uncommon in Parkinson’s Disease
por: Milikovsky, Dan Z., et al.
Publicado: (2023)

Increased frontal brain activation during walking while dual tasking: an fNIRS study in healthy young adults
por: Mirelman, Anat, et al.
Publicado: (2014)

Executive Function and Falls in Older Adults: New Findings from a Five-Year Prospective Study Link Fall Risk to Cognition
por: Mirelman, Anat, et al.
Publicado: (2012)

Higher-Level Cognitive Function and Obstacle Attributes: An fNIRS Study in Older Adults With Parkinson’s Disease
por: Hausdorff, Jeffrey, et al.
Publicado: (2020)

Combining tDCS With a Motor-Cognitive Task to Reduce the Negative Impact of Dual-Tasking on the Gait of Older Adults
por: Hausdorff, Jeffrey, et al.
Publicado: (2020)

Limited Ability to Adjust N2 Amplitude During Dual Task Walking in People With Drug-Resistant Juvenile Myoclonic Epilepsy
por: Yam, Mor, et al.
Publicado: (2022)

Abnormal gait and motor cortical processing in drug‐resistant juvenile myoclonic epilepsy
por: Maidan, Inbal, et al.
Publicado: (2023)

Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
por: Ortega, Roberto A., et al.
Publicado: (2021)

Combining transcranial direct current stimulation with a motor-cognitive task: the impact on dual-task walking costs in older adults
por: Schneider, Nofar, et al.
Publicado: (2021)

Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease
por: Thaler, Avner, et al.
Publicado: (2022)

Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
por: Bendikov-Bar, Inna, et al.
Publicado: (2013)

The Home-Based Sleep Laboratory
por: Hanein, Yael, et al.
Publicado: (2021)

Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()()
por: Xu, Yaqian, et al.
Publicado: (2020)

CCR5‐Δ32 polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients
por: Molad, Jeremy, et al.
Publicado: (2022)

Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency
por: Gatto, Emilia M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_03gaeqc7d6hmg8o2el3ica94hl